Four Novel Splice-Switch Reporter Cell Lines: Distinct Impact of Oligonucleotide Chemistry and Delivery Vector on Biological Activity

被引:12
作者
Rocha, Cristina S. J. [1 ]
Lundin, Karin E. [1 ]
Behlke, Mark A. [2 ]
Zain, Rula [1 ,3 ]
EL Andaloussi, Samir [1 ,4 ]
Smith, C. I. Edvard [1 ]
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Lab Med, Clin Res Ctr, Level 5,Halsovagen 7, S-14186 Huddinge, Sweden
[2] Integrated DNA Technol Inc, Coralville, IA USA
[3] Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, Stockholm, Sweden
[4] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England
基金
瑞典研究理事会; 英国医学研究理事会;
关键词
reporter cell lines; splice-switching oligonucleotides; pLuc; 705; delivery vectors; gymnotic delivery; oligonucleotide chemistries; C-14-LABELED PHOSPHOROTHIOATE OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDES; PENETRATING PEPTIDE; INTRACELLULAR TRAFFICKING; SOLID FORMULATION; HUMAN-DISEASE; RNA; PHARMACOKINETICS; THERAPEUTICS; THERAPIES;
D O I
10.1089/nat.2016.0631
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
New advances in oligonucleotide (ON) chemistry emerge continuously, and over the last few years, several aspects of ON delivery have been improved. However, clear knowledge regarding how certain chemistries behave alone, or in combination with various delivery vectors, is limited. Moreover, characterization is frequently limited to a single reporter cell line and, when different cell types are studied, experiments are commonly not carried out under similar conditions, hampering comparative analysis. To address this, we have developed a small tissue library of new, stable, pLuc/705 splice-switching reporter cell lines (named HuH7_705, U-2 OS_705, C2C12_705, and Neuro-2a_705). Our data show that, indeed, the cell type used in activity screenings influences the efficiency of ONs of different chemistry (phosphorothioate with locked nucleic acid or 2-O-methyl with or without N,N-diethyl-4-(4-nitronaphthalen-1-ylazo)-phenylamine). Likewise, the delivery method, Lipofectamine((R)) 2000, PepFect14 nanoparticles, or naked uptake, also demonstrates cell-type-dependent outcomes. Taken together, these cell lines can potentially become useful tools for future in vitro evaluation of new nucleic acid-based oligomers as well as delivery compounds for splice-switching approaches and cell-specific therapies.
引用
收藏
页码:381 / 391
页数:11
相关论文
共 38 条
  • [1] New Momentum for the Field of Oligonucleotide Therapeutics
    Aartsma-Rus, Annemieke
    [J]. MOLECULAR THERAPY, 2016, 24 (02) : 193 - 194
  • [2] Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
    Alam, Md Rowshon
    Dixit, Vidula
    Kang, Hyunmin
    Li, Zi-Bo
    Chen, Xiaoyuan
    Trejo, Joann
    Fisher, Michael
    Juliano, Rudy L.
    [J]. NUCLEIC ACIDS RESEARCH, 2008, 36 (08) : 2764 - 2776
  • [3] Delivery of therapeutic oligonucleotides with cell penetrating peptides
    Boisguerin, Prisca
    Deshayes, Sebastien
    Gait, Michael J.
    O'Donovan, Liz
    Godfrey, Caroline
    Betts, Corinne A.
    Wood, Matthew J. A.
    Lebleu, Bernard
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2015, 87 : 52 - 67
  • [4] COSSUM PA, 1994, J PHARMACOL EXP THER, V269, P89
  • [5] COSSUM PA, 1993, J PHARMACOL EXP THER, V267, P1181
  • [6] CROOKE RM, 1995, J PHARMACOL EXP THER, V275, P462
  • [7] Antisense strategies
    Crooke, ST
    [J]. CURRENT MOLECULAR MEDICINE, 2004, 4 (05) : 465 - 487
  • [8] RESTORATION OF CORRECT SPLICING IN THALASSEMIC PREMESSENGER RNA BY ANTISENSE OLIGONUCLEOTIDES
    DOMINSKI, Z
    KOLE, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) : 8673 - 8677
  • [9] El Andaloussi SA, 2012, CURR GENE THER, V12, P161
  • [10] Solid formulation of cell-penetrating peptide nanocomplexes with siRNA and their stability in simulated gastric conditions
    Ezzat, Kariem
    Zaghloul, Eman M.
    Andaloussi, Samir E. L.
    Lehto, Taavi
    El-Sayed, Ramy
    Magdy, Tarek
    Smith, C. I. Edvard
    Langel, Ulo
    [J]. JOURNAL OF CONTROLLED RELEASE, 2012, 162 (01) : 1 - 8